(XPEV) Xpeng - Overview
Exchange: NYSE •
Country: China •
Currency: USD •
Type: Common Stock •
ISIN: US98422D1054
Stock:
Total Rating 15
Risk 31
Buy Signal -1.14
| Risk 5d forecast | |
|---|---|
| Volatility | 60.4% |
| Relative Tail Risk | -6.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -43.45 |
| Character TTM | |
|---|---|
| Beta | 1.124 |
| Beta Downside | -0.001 |
| Drawdowns 3y | |
|---|---|
| Max DD | 71.65% |
| CAGR/Max DD | 0.32 |
EPS (Earnings per Share)
Revenue
Description: XPEV Xpeng
XPeng Inc. designs, develops, manufactures, and markets smart electric vehicles (EVs) in the People's Republic of China. The company offers P7 and P7i, a four-door sports sedan; G9, a smart EV and a mid- to large-sized sport utility vehicle (SUV); G6, a smart EV and a coupe SUV; X9, Smart EV and a large seven-seater multi-purpose vehicle (MPV); MONA M03, an all-electric hatchback coupe; and P7+, smart EV of XPeng series. It also provides XOS Tianji, smart in-car operating system; Powertrain; and SEPA 2.0, a smart electric platform architecture. In addition, the company offers various services, including services embedded in a sales contract, supercharging, maintenance, technical support, technical research and development, and second-hand vehicle sales services; and insurance technology support, and automotive loan referral and auto financing services. XPeng Inc. was founded in 2015 and is headquartered in Guangzhou, the People's Republic of China.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -2.85b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -2.74 > 1.0 |
| NWC/Revenue: 9.05% < 20% (prev 31.59%; Δ -22.54% < -1%) |
| CFO/TA -0.02 > 3% & CFO -2.01b > Net Income -2.85b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (952.7m) vs 12m ago -49.54% < -2% |
| Gross Margin: 17.08% > 18% (prev 0.11%; Δ 1697 % > 0.5%) |
| Asset Turnover: 80.77% > 50% (prev 49.47%; Δ 31.30% > 0%) |
| Interest Coverage Ratio: -5.53 > 6 (EBITDA TTM -2.01b / Interest Expense TTM 553.2m) |
Altman Z'' -1.87
| A: 0.06 (Total Current Assets 59.95b - Total Current Liabilities 53.57b) / Total Assets 98.31b |
| B: -0.44 (Retained Earnings -43.13b / Total Assets 98.31b) |
| C: -0.04 (EBIT TTM -3.06b / Avg Total Assets 87.37b) |
| D: -0.60 (Book Value of Equity -41.08b / Total Liabilities 68.32b) |
| Altman-Z'' Score: -1.87 = D |
Beneish M -3.17
| DSRI: 0.53 (Receivables 4.57b/4.59b, Revenue 70.57b/37.81b) |
| GMI: 0.67 (GM 17.08% / 11.45%) |
| AQI: 0.87 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 1.87 (Revenue 70.57b / 37.81b) |
| TATA: -0.01 (NI -2.85b - CFO -2.01b) / TA 98.31b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of XPEV shares?
As of March 04, 2026, the stock is trading at USD 15.87 with a total of 9,523,768 shares traded.
Over the past week, the price has changed by -15.27%, over one month by -7.52%, over three months by -15.90% and over the past year by -21.63%.
Over the past week, the price has changed by -15.27%, over one month by -7.52%, over three months by -15.90% and over the past year by -21.63%.
Is XPEV a buy, sell or hold?
Xpeng has received a consensus analysts rating of 4.21.
Therefore, it is recommended to buy XPEV.
- StrongBuy: 14
- Buy: 7
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the XPEV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.8 | 69.1% |
| Analysts Target Price | 26.8 | 69.1% |
XPEV Fundamental Data Overview March 03, 2026
Market Cap CNY = 117.41b (17.06b USD * 6.8826 USD.CNY)
P/E Forward = 38.1679
P/S = 0.2417
P/B = 3.8374
Revenue TTM = 70.57b CNY
EBIT TTM = -3.06b CNY
EBITDA TTM = -2.01b CNY
Long Term Debt = 6.42b CNY (from longTermDebt, last quarter)
Short Term Debt = 23.23b CNY (from shortTermDebt, last quarter)
Debt = 34.70b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.17b CNY (from netDebt column, last quarter)
Enterprise Value = 117.42b CNY (117.41b + Debt 34.70b - CCE 34.70b)
Interest Coverage Ratio = -5.53 (Ebit TTM -3.06b / Interest Expense TTM 553.2m)
EV/FCF = -26.44x (Enterprise Value 117.42b / FCF TTM -4.44b)
FCF Yield = -3.78% (FCF TTM -4.44b / Enterprise Value 117.42b)
FCF Margin = -6.29% (FCF TTM -4.44b / Revenue TTM 70.57b)
Net Margin = -4.04% (Net Income TTM -2.85b / Revenue TTM 70.57b)
Gross Margin = 17.08% ((Revenue TTM 70.57b - Cost of Revenue TTM 58.52b) / Revenue TTM)
Gross Margin QoQ = 20.14% (prev 17.33%)
Tobins Q-Ratio = 1.19 (Enterprise Value 117.42b / Total Assets 98.31b)
Interest Expense / Debt = 0.29% (Interest Expense 99.3m / Debt 34.70b)
Taxrate = 21.0% (US default 21%)
NOPAT = -2.42b (EBIT -3.06b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.12 (Total Current Assets 59.95b / Total Current Liabilities 53.57b)
Debt / Equity = 1.16 (Debt 34.70b / totalStockholderEquity, last quarter 29.99b)
Debt / EBITDA = -8.56 (negative EBITDA) (Net Debt 17.17b / EBITDA -2.01b)
Debt / FCF = -3.87 (negative FCF - burning cash) (Net Debt 17.17b / FCF TTM -4.44b)
Total Stockholder Equity = 30.58b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.26% (Net Income -2.85b / Total Assets 98.31b)
RoE = -9.33% (Net Income TTM -2.85b / Total Stockholder Equity 30.58b)
RoCE = -8.27% (EBIT -3.06b / Capital Employed (Equity 30.58b + L.T.Debt 6.42b))
RoIC = -4.79% (negative operating profit) (NOPAT -2.42b / Invested Capital 50.47b)
WACC = 7.82% (E(117.41b)/V(152.11b) * Re(10.06%) + D(34.70b)/V(152.11b) * Rd(0.29%) * (1-Tc(0.21)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -28.59%
[DCF] Fair Price = unknown (Cash Flow -4.44b)
EPS Correlation: 83.84 | EPS CAGR: 13.96% | SUE: -0.09 | # QB: 0
Revenue Correlation: 71.46 | Revenue CAGR: 26.04% | SUE: -0.00 | # QB: 0
EPS next Year (2026-12-31): EPS=2.91 | Chg7d=+0.102 | Chg30d=+0.296 | Revisions Net=+0 | Growth EPS=+339.5% | Growth Revenue=+36.0%
P/E Forward = 38.1679
P/S = 0.2417
P/B = 3.8374
Revenue TTM = 70.57b CNY
EBIT TTM = -3.06b CNY
EBITDA TTM = -2.01b CNY
Long Term Debt = 6.42b CNY (from longTermDebt, last quarter)
Short Term Debt = 23.23b CNY (from shortTermDebt, last quarter)
Debt = 34.70b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.17b CNY (from netDebt column, last quarter)
Enterprise Value = 117.42b CNY (117.41b + Debt 34.70b - CCE 34.70b)
Interest Coverage Ratio = -5.53 (Ebit TTM -3.06b / Interest Expense TTM 553.2m)
EV/FCF = -26.44x (Enterprise Value 117.42b / FCF TTM -4.44b)
FCF Yield = -3.78% (FCF TTM -4.44b / Enterprise Value 117.42b)
FCF Margin = -6.29% (FCF TTM -4.44b / Revenue TTM 70.57b)
Net Margin = -4.04% (Net Income TTM -2.85b / Revenue TTM 70.57b)
Gross Margin = 17.08% ((Revenue TTM 70.57b - Cost of Revenue TTM 58.52b) / Revenue TTM)
Gross Margin QoQ = 20.14% (prev 17.33%)
Tobins Q-Ratio = 1.19 (Enterprise Value 117.42b / Total Assets 98.31b)
Interest Expense / Debt = 0.29% (Interest Expense 99.3m / Debt 34.70b)
Taxrate = 21.0% (US default 21%)
NOPAT = -2.42b (EBIT -3.06b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.12 (Total Current Assets 59.95b / Total Current Liabilities 53.57b)
Debt / Equity = 1.16 (Debt 34.70b / totalStockholderEquity, last quarter 29.99b)
Debt / EBITDA = -8.56 (negative EBITDA) (Net Debt 17.17b / EBITDA -2.01b)
Debt / FCF = -3.87 (negative FCF - burning cash) (Net Debt 17.17b / FCF TTM -4.44b)
Total Stockholder Equity = 30.58b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.26% (Net Income -2.85b / Total Assets 98.31b)
RoE = -9.33% (Net Income TTM -2.85b / Total Stockholder Equity 30.58b)
RoCE = -8.27% (EBIT -3.06b / Capital Employed (Equity 30.58b + L.T.Debt 6.42b))
RoIC = -4.79% (negative operating profit) (NOPAT -2.42b / Invested Capital 50.47b)
WACC = 7.82% (E(117.41b)/V(152.11b) * Re(10.06%) + D(34.70b)/V(152.11b) * Rd(0.29%) * (1-Tc(0.21)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -28.59%
[DCF] Fair Price = unknown (Cash Flow -4.44b)
EPS Correlation: 83.84 | EPS CAGR: 13.96% | SUE: -0.09 | # QB: 0
Revenue Correlation: 71.46 | Revenue CAGR: 26.04% | SUE: -0.00 | # QB: 0
EPS next Year (2026-12-31): EPS=2.91 | Chg7d=+0.102 | Chg30d=+0.296 | Revisions Net=+0 | Growth EPS=+339.5% | Growth Revenue=+36.0%